ETF Managers Group’s Agios Pharmaceuticals AGIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$570K Buy
24,797
+370
+2% +$9.83K 0.02% 413
2022
Q4
$686K Buy
24,427
+890
+4% +$25.1K 0.03% 246
2022
Q3
$666K Buy
23,537
+911
+4% +$24.4K 0.02% 287
2022
Q2
$506K Buy
22,626
+9,168
+68% +$207K 0.01% 473
2022
Q1
$395K Buy
13,458
+225
+2% +$6.88K 0.01% 507
2021
Q4
$444K Buy
13,233
+630
+5% +$25.4K 0.01% 533
2021
Q3
$582K Buy
12,603
+969
+8% +$46.8K 0.01% 496
2021
Q2
$623K Buy
11,634
+2,579
+28% +$144K 0.01% 417
2021
Q1
$446K Buy
9,055
+1,218
+16% +$60.3K 0.01% 495
2020
Q4
$349K Buy
7,837
+696
+10% +$27.5K 0.01% 519
2020
Q3
$246K Buy
7,141
+355
+5% +$15.6K 0.01% 552
2020
Q2
$360K Buy
6,786
+2,710
+66% +$125K 0.01% 329
2020
Q1
$144K Buy
4,076
+416
+11% +$19.2K 0.01% 499
2019
Q4
$176K Buy
3,660
+839
+30% +$31.7K 0.01% 522
2019
Q3
$97K Sell
2,821
-30
-1% -$1.24K ﹤0.01% 521
2019
Q2
$142K Buy
2,851
+1,102
+63% +$58.9K ﹤0.01% 519
2019
Q1
$118K Buy
1,749
+157
+10% +$9.14K 0.01% 475
2018
Q4
$73K Buy
1,592
+216
+16% +$13.3K ﹤0.01% 530
2018
Q3
$106K Buy
1,376
+144
+12% +$11.6K ﹤0.01% 474
2018
Q2
$642 Buy
1,232
+29
+2% +$2.53K 0.05% 160
2018
Q1
$89K Buy
1,203
+150
+14% +$11.6K 0.01% 310
2017
Q4
$63K Buy
1,053
+150
+17% +$9.44K ﹤0.01% 450
2017
Q3
$60K Buy
903
+82
+10% +$4.92K 0.01% 253
2017
Q2
$42K Buy
+821
New +$42K ﹤0.01% 511
2016
Q1
$33K Buy
+567
New +$24.2K 0.02% 261

Other funds holding AGIO